1. Home
  2. SLS vs TAYD Comparison

SLS vs TAYD Comparison

Compare SLS & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • TAYD
  • Stock Information
  • Founded
  • SLS 2012
  • TAYD 1955
  • Country
  • SLS United States
  • TAYD United States
  • Employees
  • SLS N/A
  • TAYD N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • TAYD Industrial Machinery/Components
  • Sector
  • SLS Health Care
  • TAYD Industrials
  • Exchange
  • SLS Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • SLS 165.6M
  • TAYD 144.3M
  • IPO Year
  • SLS N/A
  • TAYD N/A
  • Fundamental
  • Price
  • SLS $1.66
  • TAYD $44.38
  • Analyst Decision
  • SLS Strong Buy
  • TAYD
  • Analyst Count
  • SLS 1
  • TAYD 0
  • Target Price
  • SLS $7.00
  • TAYD N/A
  • AVG Volume (30 Days)
  • SLS 2.8M
  • TAYD 9.5K
  • Earning Date
  • SLS 08-12-2025
  • TAYD 09-26-2025
  • Dividend Yield
  • SLS N/A
  • TAYD N/A
  • EPS Growth
  • SLS N/A
  • TAYD 1.48
  • EPS
  • SLS N/A
  • TAYD 2.50
  • Revenue
  • SLS N/A
  • TAYD $42,796,782.00
  • Revenue This Year
  • SLS N/A
  • TAYD $15.06
  • Revenue Next Year
  • SLS N/A
  • TAYD $8.37
  • P/E Ratio
  • SLS N/A
  • TAYD $17.73
  • Revenue Growth
  • SLS N/A
  • TAYD N/A
  • 52 Week Low
  • SLS $0.77
  • TAYD $29.50
  • 52 Week High
  • SLS $2.27
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • SLS 41.18
  • TAYD 49.89
  • Support Level
  • SLS $1.75
  • TAYD $44.63
  • Resistance Level
  • SLS $1.96
  • TAYD $47.46
  • Average True Range (ATR)
  • SLS 0.12
  • TAYD 1.82
  • MACD
  • SLS -0.04
  • TAYD -0.45
  • Stochastic Oscillator
  • SLS 18.56
  • TAYD 17.17

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: